ImpediMed Stock

ImpediMed EPS

The Earnings per Share (EPS) of ImpediMed (IPD.AX) as of Jun 22, 2026 is -0.01 AUD.In the previous year, Earnings per Share (EPS) was -0.01 AUD — a change of 17.57% (lower).

EPS

-0.01AUD

YoY

17.57%

Last updated:

Earnings per Share (EPS) of ImpediMed is 2026 -0.01 AUD. Earnings per Share (EPS) of ImpediMed was 2025 -0.01 AUD. It decreases by 17.57% lower compared to the previous year.
Access this data via the Eulerpool API

ImpediMed Stock analysis

What does ImpediMed do? ImpediMed Ltd is an Australian company specializing in medical devices and technologies. They were founded in 1999 and have their headquarters in Brisbane, Australia. The company is a leading provider of bioimpedance measurement devices for the diagnosis, monitoring, and treatment of lymphatic, cardiac, and other medical conditions. They have a wide range of products used in various medical fields, including oncology, lymphology, and cardiology. Their main business model is based on the development and marketing of their bioimpedance measurement devices. They also provide training and support for medical personnel to optimize the use of their devices. ImpediMed specializes in the diagnosis and treatment of lymphedema in the oncology sector, particularly using their highly precise L-Dex® device. They also analyze body composition in the cardiology sector to determine the risk of heart diseases and develop personalized treatment approaches. In recent years, ImpediMed has expanded into the European market, particularly in lymphedema diagnosis and treatment. Overall, ImpediMed Ltd is an innovative company that focuses on medical devices and technologies for the diagnosis and monitoring of cardiac and lymphatic diseases. They provide important diagnostic capabilities to medical professionals and continue to focus on growth and expansion. ImpediMed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ImpediMed stock

Earnings per Share (EPS) of ImpediMed amounted to -0.01 AUD -0.01

Access this data via the Eulerpool API

Income Statement — ImpediMed

All Key Metrics — ImpediMed